Hypertension Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hypertension stocks.

Hypertension Stocks Recent News

Date Stock Title
May 8 EHAB Enhabit GAAP EPS of $0.01, revenue of $262.4M
May 8 EHAB Enhabit concludes review of strategic alternatives
May 8 EHAB Enhabit Concludes Review of Strategic Alternatives
May 8 EHAB Enhabit Reports First Quarter 2024 Financial Results
May 8 UTHR Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
May 8 ASND An Update On Ascendis Pharma's Path To Profitability
May 7 OCUL Ocular Therapeutix Inc Reports First Quarter 2024 Earnings
May 7 OCUL Ocular Therapeutix GAAP EPS of -$0.49 misses by $0.29, revenue of $14.77M misses by $0.59M
May 7 OCUL Ocular Therapeutix™ Reports First Quarter 2024 Results
May 7 UTHR Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
May 7 EHAB Surgery Partners (SGRY) Q1 Earnings and Revenues Beat Estimates
May 7 LQDA Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
May 7 LQDA Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
May 7 UTHR Best Value Stocks to Buy for May 7th
May 7 UTHR Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
May 7 UTHR Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)
May 7 OCUL Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 6 OCUL Ocular Therapeutix Q1 2024 Earnings Preview
May 6 UTHR United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons Why
May 6 ASND Ascendis Pharma A/S (NASDAQ:ASND) Q1 2024 Earnings Call Transcript
Hypertension

Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. High blood pressure typically does not cause symptoms. Long-term high blood pressure, however, is a major risk factor for coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral vascular disease, vision loss, chronic kidney disease, and dementia.High blood pressure is classified as either primary (essential) high blood pressure or secondary high blood pressure. About 90–95% of cases are primary, defined as high blood pressure due to nonspecific lifestyle and genetic factors. Lifestyle factors that increase the risk include excess salt in the diet, excess body weight, smoking, and alcohol use. The remaining 5–10% of cases are categorized as secondary high blood pressure, defined as high blood pressure due to an identifiable cause, such as chronic kidney disease, narrowing of the kidney arteries, an endocrine disorder, or the use of birth control pills.Blood pressure is expressed by two measurements, the systolic and diastolic pressures, which are the maximum and minimum pressures, respectively. For most adults, normal blood pressure at rest is within the range of 100–130 millimeters mercury (mmHg) systolic and 60–80 mmHg diastolic. For most adults, high blood pressure is present if the resting blood pressure is persistently at or above 130/80 or 140/90 mmHg. Different numbers apply to children. Ambulatory blood pressure monitoring over a 24-hour period appears more accurate than office-based blood pressure measurement.Lifestyle changes and medications can lower blood pressure and decrease the risk of health complications. Lifestyle changes include weight loss, physical exercise, decreased salt intake, reducing alcohol intake, and a healthy diet. If lifestyle changes are not sufficient then blood pressure medications are used. Up to three medications can control blood pressure in 90% of people. The treatment of moderately high arterial blood pressure (defined as >160/100 mmHg) with medications is associated with an improved life expectancy. The effect of treatment of blood pressure between 130/80 mmHg and 160/100 mmHg is less clear, with some reviews finding benefit and others finding unclear benefit. High blood pressure affects between 16 and 37% of the population globally. In 2010 hypertension was believed to have been a factor in 18% of all deaths (9.4 million globally).

Browse All Tags